BG Medicine (OTCMKTS:BGMD) Shares Down 25%

BG Medicine, Inc. (OTCMKTS:BGMD) shares were down 25% on Monday . The company traded as low as $0.02 and last traded at $0.02. Approximately 500 shares traded hands during trading, a decline of 63% from the average daily volume of 1,356 shares. The stock had previously closed at $0.02.

The company has a fifty day moving average price of $0.02.

COPYRIGHT VIOLATION NOTICE: “BG Medicine (OTCMKTS:BGMD) Shares Down 25%” was posted by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this report on another publication, it was illegally stolen and republished in violation of United States & international copyright laws. The original version of this report can be viewed at

BG Medicine Company Profile (OTCMKTS:BGMD)

BG Medicine, Inc engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke.

Featured Article: Penny Stocks, What You Need To Know

Receive News & Ratings for BG Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BG Medicine and related companies with's FREE daily email newsletter.